Giant magnetoresistance of CuCoX alloys produced by liquid quenching

1994 ◽  
Vol 181-182 ◽  
pp. 888-891 ◽  
Author(s):  
Noriyuki Kataoka ◽  
Ick Jun Kim ◽  
Hideki Takeda ◽  
Kazuaki Fukamichi ◽  
Yutaka Shimada
1993 ◽  
Vol 32 (Part 1, No. 5A) ◽  
pp. 1969-1970 ◽  
Author(s):  
Noriyuki Kataoka ◽  
Hiroshi Endo ◽  
Kazuaki Fukamichi ◽  
Yutaka Shimada

1998 ◽  
Vol 22 (4_2) ◽  
pp. 537-540 ◽  
Author(s):  
Y. Seyama ◽  
M. Iijima ◽  
A. Tanaka ◽  
M. Oshiki

Author(s):  
T. Kimura

This chapter discusses the spin-transfer effect, which is described as the transfer of the spin angular momentum between the conduction electrons and the magnetization of the ferromagnet that occurs due to the conservation of the spin angular momentum. L. Berger, who introduced the concept in 1984, considered the exchange interaction between the conduction electron and the localized magnetic moment, and predicted that a magnetic domain wall can be moved by flowing the spin current. The spin-transfer effect was brought into the limelight by the progress in microfabrication techniques and the discovery of the giant magnetoresistance effect in magnetic multilayers. Berger, at the same time, separately studied the spin-transfer torque in a system similar to Slonczewski’s magnetic multilayered system and predicted spontaneous magnetization precession.


2011 ◽  
Vol 98 (4) ◽  
pp. 042503 ◽  
Author(s):  
Tomohiro Taniguchi ◽  
Hiroshi Imamura ◽  
Tomoya M. Nakatani ◽  
Kazuhiro Hono

1996 ◽  
Vol 37 (11) ◽  
pp. 1710-1714 ◽  
Author(s):  
Ryoichi Nakatani ◽  
Katsumi Hoshino ◽  
Hiroyuki Hoshiya ◽  
Yutaka Sugita

Author(s):  
Fanda Meng ◽  
Weisong Huo ◽  
Jie Lian ◽  
Lei Zhang ◽  
Xizeng Shi ◽  
...  

AbstractWe report a microfluidic sandwich immunoassay constructed around a dual-giant magnetoresistance (GMR) sensor array to quantify the heart failure biomarker NT-proBNP in human plasma at the clinically relevant concentration levels between 15 pg/mL and 40 ng/mL. The broad dynamic range was achieved by differential coating of two identical GMR sensors operated in tandem, and combining two standard curves. The detection limit was determined as 5 pg/mL. The assay, involving 53 plasma samples from patients with different cardiovascular diseases, was validated against the Roche Cobas e411 analyzer. The salient features of this system are its wide concentration range, low detection limit, small sample volume requirement (50 μL), and the need for a short measurement time of 15 min, making it a prospective candidate for practical use in point of care analysis.


Sign in / Sign up

Export Citation Format

Share Document